image
Intra-Cellular Therapies, Inc. ITCI
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 83.42
-4.8 %
$ 8.84 B
Market Cap
-100.51
P/E
BALANCE SHEET
728 M ASSETS
-3.51%
Growth Rates
1Year -3.51%
3Years 0.51%
5Years 15.31%
7Years 9.38%
10Years 34.20%
137 M LIABILITIES
38.66%
Growth Rates
1Year 38.66%
3Years 31.31%
5Years 28.22%
7Years 39.37%
10Years 34.95%
591 M EQUITY
-9.85%
Growth Rates
1Year -9.85%
3Years -3.44%
5Years 13.23%
7Years 6.70%
10Years 34.03%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Intra-Cellular Therapies, Inc.
image
Current Assets 668 M
Cash & Short-Term Investments 498 M
Receivables 114 M
Other Current Assets 55.8 M
Non-Current Assets 60.5 M
Long-Term Investments 0
PP&E 14.6 M
Other Non-Current Assets 45.9 M
Current Liabilities 124 M
Accounts Payable 11.5 M
Short-Term Debt 7.22 M
Other Current Liabilities 105 M
Non-Current Liabilities 13.3 M
Long-Term Debt 13.3 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Mar-2013
ASSETS
Cash & Cash Equivalents 147.8 148.6 92.4 60.0 107.6 54.9 37.8 48.6 47.2 61.3 35.2 19.1
Short Term Investments 350.2 443.3 320.0 597.4 116.4 292.6 426.5 335.5 428.0 68.3 2.0 3.5
Receivables 114.0 75.2 20.2 10.8 0 0 0 94.3 K 30.7 K 51.6 K 0.3 0.3
Inventory 11.6 23.9 7.9 7.1 0 0 0 1 1 0 1 1
Other Current Assets 44.2 46.9 26.8 15.6 6.3 7.9 4.9 4.0 8.0 1.3 0.8 0.2
Total Current Assets 667.8 738.0 467.3 690.9 230.3 355.4 469.2 388.2 483.3 131.0 38.2 19.6
PP&E 14.6 16.7 22.6 26.3 20.5 1.2 1.1 0.6 0.8 54.6 K 68.3 K 58.3 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 45.9 86 K 86.1 K 86.1 K 86.1 K 78.8 K 75.8 K 75.8 K 71.9 K 70.9 K 0.1 0.1
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 728.3 754.8 489.9 717.3 251.2 357.2 471.5 388.9 484.1 131.1 38.4 19.8
LIABILITIES
Accounts Payable 11.5 10.4 8.7 5.5 7.4 14.0 6.2 3.8 1.6 2.1 3.4 41.6 K
Short Term Debt 7.2 9.1 6.7 5.5 3.2 0 0 0 0 0 0 0
Other Current Liabilities 104.9 63.7 37.9 25.8 25.6 22.3 8.0 6.8 4.6 8.5 3.4 1.1
Total Current Liabilities 123.5 83.2 53.4 36.9 36.2 36.3 14.2 10.5 6.3 10.6 6.8 2.8
Long Term Debt 13.3 15.5 18 693.6 23.6 20.0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 (18 674.9) 0 0 3.2 2.8 2.9 1.6 0 0 0
Total Liabilities 136.9 98.7 72.0 60.5 56.2 39.5 17.0 13.4 7.9 10.6 6.8 2.8
EQUITY
Common Stock 10 K 9 K 8.19 K 8.05 K 5.55 K 5.49 K 5.46 K 4.33 K 4.32 K 2.95 K 2.22 K 1.46 K
Retained Earnings (1 617.2) (1 477.5) (1 221.2) (937.1) (710.1) (562.4) (407.2) (309.5) (193.0) (88.3) (57.6) (30.7)
Other Accumulative Comprehensive Income/Loss 0.1 (4.2) (0.4) 0.5 0.1 (0.7) (0.8) (0.3) (0.6) (0.1) 0 (3.2)
Total Equity 591.4 656.1 417.9 656.9 195.0 317.7 454.4 375.5 476.2 120.6 31.6 17.0
Total Liabilities and Equity 728.3 754.8 489.9 717.3 251.2 357.2 471.5 388.9 484.1 131.1 38.4 19.8
SHARES OUTSTANDING
Common Shares Outstanding 95.9 94.0 81.3 70.4 55.2 54.7 46.2 43.2 36.0 28.7 17.2 22.2